2026.04.22
Development of therapeutic applications for intractable neurological and muscular diseases based on innovative nucleic acid drug technology

2026.04.22
Development of therapeutic applications for intractable neurological and muscular diseases based on innovative nucleic acid drug technology
2026.04.21
Development of innovative cancer treatment modalities with enhanced performance through the integration of viral vector platform technologies

2026.04.21
Research and development of antibody-drug conjugates targeting the stroma of pancreatic cancer

2026.04.20
QST develops drug that enables both diagnosis and treatment simply by swapping radionuclides — Single dose suppresses tumor growth in both primary and metastatic lesions

2026.04.17
Predictive model developed to improve accuracy of blood-based comprehensive genomic profiling

2026.04.17
Kaempferol, a component of horseradish leaves, confirmed to activate mitochondria

2026.04.15
Clinical development of cancer-specific antibodies based on the CasMab method

2026.04.15
Development of a novel treatment for the predominant Japanese mutation in glycogen storage disease Type Ia using novel high-performance splice-switching oligonucleotides

2026.04.15
MYCN gene expression as an indicator for predicting the risk of liver cancer development

2026.04.14
Chiba University and RIKEN establish master cell bank for immune cells generated from iPS cells — Safety confirmed and clinical trial shows signs of therapeutic efficacy

2026.04.10
New treatment strategy for acute myeloid leukemia proposed by Tokai University

2026.04.10
Fish protein prevents short-term memory decline — Improved gut environment suppresses brain inflammation

2026.04.08
Research and development of systemically administered antitumor nucleic acid drug MIRX006 based on microRNA
2026.04.07
Government council recommends formulating MCM strategy for infectious disease countermeasures

2026.04.07
Development of gain of function enzyme mRNA therapeutics to overcome the challenges of protein replacement therapy

2026.04.06
Research and Development Program for Innovative Biologics — Toward the creation of innovative high-performance biologics originating from Japan

2026.04.03
Highly pathogenic avian influenza virus is inactivated by photocatalyst — Results from the University of Tokyo

2026.04.02
AMED produces guide for university researchers to founding drug discovery ventures — Investor support and IP strategy explained

2026.04.01
Protein responsible for chronic inflammation identified — Opening the door to new treatments for asthma and autoimmune diseases

2026.03.31
Kyoto medical firm to launch personal iPS cell storage service

2026.03.30
Bless you, macaques: Hay fever hits Japan's wild monkey parks

2026.03.25
So tiny! Working toward the day a "digital pill" charged by stomach acid monitors your gut

2026.03.25
Oral administration of kidney drug "finerenone" effective against premature ovarian insufficiency

2026.03.19
Gut bacteria linked to brain and nerve diseases — Peyer's patch T cells found to trigger encephalomyelitis
Medicine